Novel Resilience Genes Required for Cerebellum Development and Medulloblastoma Survival |
University of California San Francisco / Stephen Fancy, PhD, DVM |
Innovation Grants |
2023 |
California |
Neuronal Damage, Neurocognitive Losses and Quality of Life Following High-Dose Chemotherapy in Children with Brain Tumors |
Children’s Hospital Los Angeles / Mary Nelson |
Nurse Researcher Grants |
2009 |
California |
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD |
Innovation Grants |
2015 |
California |
Investigating the Role of Genetic and Epigenetic Variation in Risk of Childhood Acute Lymphoblastic Leukemia in Down Syndrome |
University of California San Francisco / Adam de Smith, Ph.D. |
'A' Award Grants |
2014 |
California |
A comprehensive public resource for fusion-negative sarcoma sequencing data |
University of California San Francisco / Alejandro Sweet-Cordero, MD & Richard Gorlick, MD |
Crazy 8 Pilots |
2019 |
California |
Modeling Pediatric Leukemia in Zebra Fish to Enable Discovery of New Anti- Leukemic Compounds |
University of California, San Diego / David Traver, MD |
Innovation Grants |
2010 |
California |
A Cell Morphology Landscape of Pediatric Cancer Cell Lines |
University of Colorado Denver_ Anschutz Medical Campus / Gregory Way, PhD |
'A' Award Grants |
2023 |
Colorado |
Children's Hospital Colorado Experimental Therapeutics Program |
Children’s Hospital Colorado / Lia Gore, MD |
Phase I/II Infrastructure Grants |
2013 |
Colorado |
Expanding access to new agents for children with refractory cancers: the experimental therapeutics program at Children's Hospital of Colorado.
|
Children’s Hospital Colorado / Lia Gore, MD |
Phase I/II Infrastructure Grants |
2009 |
Colorado |
Expanding Access to New Agents for Cancer Treatment.
|
Children’s Hospital Colorado / Lia Gore, MD |
Phase I/II Infrastructure Grants |
2006 |
Colorado |